Search

everythinglearnresearchcommunity

for

Search:↓

Nanoemulsions improve drug delivery and skincare effectiveness.

Older patients with advanced kidney cancer can be managed with a drug called Sunitinib.

Sex hormones affect reproduction, sexual development, and oral health, and it's important for dental practitioners to understand their effects and interactions.

Docetaxel, a chemotherapy drug, was reported to cause psoriasis in a patient for the first time.

Many medications can cause hair loss or excessive hair growth, which is usually reversible after stopping the drug.

A bald man grew hair on his head after taking a drug called diazoxide, but lost it again when he stopped the medication.

Severe anti-TNF-α induced scalp eruptions often need stopping the drug and using systemic therapy to avoid scarring.

Low-dose anti-androgen drugs and certain drug combinations are effective for hirsutism, and insulin sensitizers show promise, especially for those with polycystic ovarian syndrome.

Some people with severe hair loss saw hair regrowth after a specific light and drug treatment.

Baricitinib helps regrow hair in adults with severe alopecia better than a placebo and is approved for treatment, but long-term effects are still unknown.

A young woman with kidney cancer experienced rare hair loss from a cancer drug and unusual cancer spread, suggesting early drug treatment might reduce spread and prolong survival.

Sorafenib can cause a temporary skin condition that goes away after stopping the drug.

Low-intensity ultrasound may protect hair follicles from damage caused by a common chemotherapy drug.

The conclusion is that more research is needed to understand if the drug finasteride causes Post-Finasteride Syndrome or if it's due to individual genetic makeup.

Valproic acid can cause muscle damage and liver issues, which improve after stopping the drug.

Half of the patients treated with a specific drug for skin cancer experienced hair loss not related to the drug's dosage.

A hemodialysis patient's hair loss was caused by the drug tinzaparin but stopped after switching to a different drug.

Tofacitinib, an arthritis drug, helped hair growth in alopecia universalis but long-term safety needs more research.

Human hair-derived particles can effectively carry and release the cancer drug Paclitaxel in a pH-sensitive manner, potentially targeting cancer cells while sparing healthy ones.

Ponatinib can cause a rare skin reaction that resolves with topical treatment and temporary drug discontinuation.

A woman with acromegaly experienced severe hair loss from a drug called Lanreotide Autogel, which improved after stopping the treatment.

A woman's hair loss was probably caused by the antifungal drug anidulafungin.

A woman's hair turned gray and fell out after starting a cancer drug called imatinib mesylate.

The book concludes that despite progress, cancer drug treatments have not met the expectations set in the 1960s and 1970s.

A cancer patient developed a type of hair loss after starting a cancer drug called vandetanib.

Minoxidil is less effective on eyebrows and eyelashes than scalp hair because these areas have lower enzyme activity needed to activate the drug.

The document concludes that various medications and treatments can have significant, sometimes adverse, effects on health outcomes.

Two people lost hair unexpectedly after getting a common hair loss treatment with a drug called Dutasteride.

A woman developed psoriasis after taking certolizumab pegol, improving after stopping the drug and starting other treatments.

Skin enzymes convert topical drugs into active forms, affecting drug effectiveness and safety.